Cargando…

ORF8a as a viroporin in SARS-CoV-2 infection?

Detalles Bibliográficos
Autor principal:	Zandi, Milad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327632/ https://www.ncbi.nlm.nih.gov/pubmed/34362671 http://dx.doi.org/10.1016/j.cytogfr.2021.07.002

Ejemplares similares

ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV
por: Zandi, Milad
Publicado: (2022)

ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion
por: Zandi, Milad
Publicado: (2022)

SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
por: Xu, Huanzhou, et al.
Publicado: (2022)

Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites
por: Fam, Marina Sherif, et al.
Publicado: (2023)

Viroporin Activity of SARS-CoV E Protein
por: Liao, Ying, et al.
Publicado: (2006)

Atomic structure of the open SARS-CoV-2 E viroporin
por: Medeiros-Silva, João, et al.
Publicado: (2023)

Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2
por: Breitinger, Ulrike, et al.
Publicado: (2022)

SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
por: Mohammad, Sameer, et al.
Publicado: (2020)

How many SARS-CoV-2 “viroporins” are really ion channels?
por: Harrison, Neil L., et al.
Publicado: (2022)

Characterization of the SARS‐CoV‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
por: Cao, Yipeng, et al.
Publicado: (2021)

Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022)

Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors
por: Breitinger, Ulrike, et al.
Publicado: (2021)

SARS-CoV-2 infection alkalinizes the ERGIC and lysosomes through the viroporin activity of the viral envelope protein
por: Wang, Wen-An, et al.
Publicado: (2023)

Molecular and Biochemical Characterization of the SARS-CoV Accessory Proteins ORF8a, ORF8b and ORF8ab
por: Keng, Choong-Tat, et al.
Publicado: (2009)

Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy
por: Fani, Mona, et al.
Publicado: (2023)

Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022)

Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2
por: Zinzula, Luca
Publicado: (2021)

SARS-CoV-2 as a betacoronavirus comprises five structural proteins?
por: Zandi, Milad, et al.
Publicado: (2021)

Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
por: Wu, Xin, et al.
Publicado: (2022)

SARS-CoV-2 ORF8 accessory protein is a virulence factor
por: Bello-Perez, M., et al.
Publicado: (2023)

Immune evasion via SARS-CoV-2 ORF8 protein?
por: Park, Matthew D.
Publicado: (2020)

Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene
por: Pereira, Filipe
Publicado: (2020)

Viroporins
por: Hyser, Joseph M.
Publicado: (2015)

A unique view of SARS-CoV-2 through the lens of ORF8 protein
por: Hassan, Sk Sarif, et al.
Publicado: (2021)

Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection
por: Lin, Xiaoyuan, et al.
Publicado: (2023)

Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
por: Hachim, Asmaa, et al.
Publicado: (2020)

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
por: Li, Jin-Yan, et al.
Publicado: (2020)

Microsecond molecular dynamics simulations revealed the inhibitory potency of amiloride analogs against SARS-CoV-2 E viroporin
por: Jaber, Abdullah All, et al.
Publicado: (2021)

SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer
por: Matsuoka, Kazuhiro, et al.
Publicado: (2022)

SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin
por: Pereira, Filipe
Publicado: (2021)

Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications
por: Valcarcel, Antonio, et al.
Publicado: (2021)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

SARS-CoV-2–encoded ORF8 protein possesses complement inhibitory properties
por: Kumar, Jitendra, et al.
Publicado: (2023)

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway
por: Lin, Xiaoyuan, et al.
Publicado: (2021)

Death by viroporin
por: Jones, Susan
Publicado: (2007)

Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein
por: Flower, Thomas G., et al.
Publicado: (2021)

Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV
por: Li, Gun, et al.
Publicado: (2021)

In silico Analysis of SARS-CoV-2 ORF8-Binding Proteins Reveals the Involvement of ORF8 in Acquired-Immune and Innate-Immune Systems
por: Takatsuka, Hisashi, et al.
Publicado: (2022)

Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8
por: Tang, Zhizhong, et al.
Publicado: (2023)

Conjugation with 8-arm PEG and CRM(197) enhances the immunogenicity of SARS-CoV-2 ORF8 protein
por: Tang, Xiaozhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_og3hsdpqp3id3kf77v8favjg9r